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bleeding, and death.7,8 However, home treatment was
studied in these investigations in selected patients: in the
two trials together, more than 50% of the patients could not
be included, for reasons such as a history of earlier throm-
boembolism, geographic inaccessibility, likelihood of non-
compliance, recurrent thrombosis, or other undefined
reasons. Some of the patients randomized to the LMWH
treatment group were hospitalized for more than 48 hours
without any information as to why. Two other studies
reported an expanding eligibility for home treatment, but
did not evaluate consecutive patients.9,10 One study
reported a 93% eligibility rate for home treatment under the
conditions of a private practice. Mainly younger patients
without severe comorbidity were included.11 Hence, in the
studies performed so far, a large number of patients with
DVT were excluded, and because of patient preselection in
these studies, the proportion of DVT patients eligible for
home treatment has not been defined. The aim of our study
was to show which patients from the overall DVT popula-
tion can be treated in an outpatient setting, to show the rea-
sons for admitting patients in whom outpatient treatment is
not suitable for the hospital, and to define the different
characteristics of inpatients and outpatients.
METHODS
Patients. A total of 202 consecutive patients with
acute DVT of the lower extremity who came to the vascu-
lar diagnostics unit of the University Hospital of Dresden,
Until recently, standard treatment of deep venous
thrombosis (DVT) consisted of continuous intravenous
infusion with unfractionated heparin (UFH) in the hospital
for 5 to 7 days, followed by oral anticoagulation with vita-
min K antagonists.1 Anticoagulation with low–molecular-
weight heparin (LMWH) has been shown to be at least as
safe and effective as UFH.2-4 Furthermore, LMWH can be
administered subcutaneously once or twice daily and does
not require monitoring of partial thromboplastin time.5
Bed rest as an additional therapeutic measure has been
shown to be inappropriate.6 Two recent studies showed
that outpatient management of DVT with LMWH is as safe
and effective as hospital treatment with UFH for the out-
comes of recurrent venous thromboembolism (VTE),
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Purpose: Home treatment of deep vein thrombosis (DVT) has been shown to be safe and effective. However, this con-
clusion has been drawn from studies with predefined patient selection criteria. Eligibility for home treatment has never
been properly assessed.
Methods: In a 9-month period, we prospectively evaluated the possible reasons for hospital treatment in consecutive
patients with acute DVT by using a check list that included medical reasons, home care situation, preferences, and hos-
pital service logistics. Treatment consisted of low–molecular-weight heparin and concomitant oral vitamin K antago-
nists and compression therapy. A 3-month follow-up examination included assessment of recurrent venous
thromboembolism (VTE), bleeding events, and mortality.
Results: A total of 202 patients were included in the study; 117 patients (58%) were outpatients and 85 patients (42%)
were hospitalized before DVT diagnosis. Of the 117 outpatients, 95 (81%) were considered eligible for home treat-
ment. Only two patients (1.7%) were admitted to the hospital for DVT-related morbidity, one (0.85%) because of
comorbidity, 11 (9.4%) for home care reasons, and eight (6.83%) because of hospital service logistics. Of the hospital-
ized patients, 79 (92.94%) remained inpatients, and six (7.05%) could be discharged within 48 hours. The only reason
for hospitalization was pre-existing comorbidity. In outpatients, the outcome after 3 months showed a 4% rate of recur-
rent VTE, no major bleeding, and an 8% mortality rate; 75% of deaths were caused by cancer. No patient died of VTE.
In inpatients, a statistically significant higher mortality rate was found (8% vs 19%; P < .02).
Conclusion: Less than 3% of patients with DVT who were outpatients had to be hospitalized because of DVT morbid-
ity. For the entire DVT population, the main reason for hospital treatment is comorbidity, rather than management
issues or DVT morbidity. (J Vasc Surg 2001;34:1065-70.)
Germany, which is a 1250-bed teaching hospital, between
Nov 1, 1998, and Aug 15, 1999, were prospectively
examined. Diagnostic examinations are performed in this
unit for all hospitalized patients and for patients referred
by general practitioners or by other medical and surgical
specialists from the area. This central unit treats all outpa-
tients with DVT in this medical facility and is the only
diagnostic center where patients with popliteal, femoral,
or iliac thrombosis are treated in Dresden (population,
470,000). The inclusion criterion was DVT diagnosed by
means of ultrasound scanning in one or more segments of
the deep leg veins. Exclusion criteria were isolated calf
muscle vein thrombosis, isolated thrombosis in the super-
ficial veins, and signs and symptoms of DVT that had
lasted for more than 2 weeks. The study protocol was
approved by the hospital ethics committee, and written
informed consent was obtained from all patients. A small
part of our data focusing only on those patients who were
outpatients without any information about patient charac-
teristics and outcomes have been accepted as a “short
report” in the British Medical Journal.12
Admission investigations. Diagnosis was established
by means of venous ultrasound scanning (UM9 HDI, lin-
ear array 4-7 MHZ, ATL, Bothell, Wash). The diagnostic
criterion for DVT was the lack of compressibility of one or
more segments of the deep veins from the calf to the infe-
rior vena cava. The duration of DVT was estimated
according to patient history.
We used a questionnaire to take patient histories about
symptoms of DVT and pulmonary embolism (PE). Risk
factors evaluated included earlier DVT or PE, surgery and
trauma, immobilization, known hypercoagulable state,
and cancer.
Treatment regimens. After diagnosis, LMWH
(Nadroparin; 90 anti Xa U/kg body weight twice a day)
was administered subcutaneously in all patients, and oral
anticoagulation treatment with phenprocoumon was
started simultaneously (therapeutic international normal-
ized ratio [INR] range, 2-3). Treatment with heparin was
continued until INR values were shown to be 2.0 or
higher in two measurements, with an interval of 24 hours
between measurements. Because compression therapy in
DVT after diagnosis is the standard of care in Germany, all
patients received graduated class II stockings with a com-
pression of 35 mm Hg at the ankle, which were available
in six different sizes. Compression bandages were used
when none of the sizes were suitable (12%). Patients were
taught how to give themselves subcutaneous injections by
a nurse and then administered the first dose of LMWH
themselves. If the patient was not capable of injecting him-
self, a family member was trained or a professional nursing
system was organized.
The patient received further information about oral
anticoagulation treatment and a brochure about the 24-
hour availability of emergency facilities. When the general
practitioner agreed with outpatient treatment, further
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Table I. Reasons for hospital treatment in 202 consecutive patients with acute deep vein
thrombosis
All reasons (%)* Main reason (%)†
Medical reasons
Comorbidity as assessed by referring physician 81 (40%) 81 (40%)
Cancer 28 (14%)
Oxygen-dependent PE 14 (7%)
Hip/knee surgery 14 (7%)
Other surgery 2 (1%)
Other 12 (11%)
Comorbidity as assessed by diagnosing physician 3 (1.5%) 3 (1.5%)
DVT symptoms 2 (1%) 2 (1%)
Previously unknown comorbidity 1 (0.5%) 1 (0.5%)
Home care situation
Injection of LMWH
Family situation 7 (3.5%) 7 (3.5%)
Compliance 5 (2.5%) 1 (0.5%)
Oral anticoagulation
Distance to hospital 5 (2.5%)
Distance to GP 1 (0.5%) 1 (0.5%)
Compression therapy 4 (2%) 0
Preferences
Patient preferences 4 (2%) 2 (1%)
GP preferences 3 (1.5%) 0
Hospital logistics and scheduling
Weekend, holiday 7 (3.5%) 7 (3.5%)
Time of day 4 (2%) 4 (2%)
*Multiple reasons/patient possible.
†One reason possible.
PE, Pulmonary embolism; DVT, deep vein thrombosis; LMWH, low–molecular-weight heparin; GP, general practitioner.
management was coordinated: oral anticoagulation,
repeated platelet count 5 to 7 days after the initiation of
LMWH therapy as a means of detecting heparin-induced
thrombocytopenia, and compression stockings.
Patient selection. The decision for inpatient or out-
patient management was based on a predefined checklist
in outpatients and hospitalized patients. We considered
four main topics to be important: medical reasons, home
care situation, preferences of the general practitioner and
the patient, and hospital service logistics.
To define the medical situation of the patient, DVT
morbidity was examined first: measurement of the circum-
ference of both legs at defined points, anamnesis for symp-
toms of DVT and PE, and evaluation of DVT risk factors.
After that, possible medical reasons for hospitalization
were investigated, including medical history and clinical
examination. In all patients, an electrocardiogram, a
Doppler examination of the peripheral arterial blood
stream, and a laboratory examination including hemoglo-
bin, white blood cell, platelet, fibrinogen, INR, and crea-
tinine levels and a prostate specific antigen level in male
patients were performed. Echocardiography, perfusion/
ventilation lung scan, or both were performed at the least
suspicion of PE.
Furthermore, the recommendation of the referring
physician or the physician who had diagnosed DVT was
taken into consideration.
The home care situation of the patient was assessed by
means of a questionnaire, which examined age, state of liv-
ing (alone, with a partner, or in a family), housing condi-
tions (floor of the apartment, elevator), profession,
mobility (dependence or independence on others in social
life), and geographical accessibility to the vascular unit and
the general practitioner (GP). The home care situation was
assessed with the aim of estimating the patient’s ability to
comply with the anticoagulation and compression therapy.
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The GP was then contacted and informed. We asked
for the GP’s opinion about home treatment, because of
his better knowledge of the patient’s medical history, com-
pliance, and social situation. The GP was asked to share
responsibility for anticoagulation, cancer screening (lung
X-ray, sonography of abdomen, gynecological examina-
tion), and platelets on day 7 after starting heparin. No
patient was sent home without us having received infor-
mation from and the agreement of the GP. The main issue
in the social evaluation and the evaluation of the GP´s
opinion was to investigate whether anticoagulation (injec-
tion of LMWH, oral anticoagulation, and accessibility for
INR testing) and compression therapy were guaranteed in
an outpatient setting— either the patient being able to
guarantee it or to guarantee it with the support of profes-
sional nursing care. Furthermore, the patients’ preferences
were assessed.
Finally, hospital service logistics were assessed. Patients
who came to the diagnostic unit after 5 PM. or on week-
ends were hospitalized because of hospital schedules and
until it was possible to contact the GP.
After evaluation of all these different points, the physician
at the vascular diagnostics unit made the final decision to
treat the patient in an outpatient setting or in the hospital.
Outpatient treatment was defined as treatment out of
the hospital beginning less than 48 hours after diagnosis.
Follow-up. In all patients, recurrent VTE, major
bleeding, and death were assessed at follow-up examina-
tions scheduled on day 3 after diagnosis, day 5 to 7, day
10 to 12, after 4 weeks, and after 3 months.
Recurrent DVT was diagnosed by means of venous
ultrasound scanning and was defined as a lack of com-
pressibility in vein segments previously unaffected or an
increase in residual diameter during compression of 2 mm
or more.13 A ventilation/perfusion lung scan was used as
a means of diagnosing PE. In the case of an intermediate
Table II. Patient characteristics
Patient characteristics
Outpatients Inpatients
Characteristic (n = 101) (n = 101) P value
Median age (range/years) 63 (19-95) 64 (12-92) NS
Male/female 42/59 39/62 NS
Localization of proximal extension of thrombus
Calf veins 31 (31%) 31 (31%) NS
Popliteal veins 16 (16%) 9 (9%) NS
Femoral veins 42 (42%) 38 (38%) NS
Iliac veins 10 (10%) 21 (21%) < .05
Vena cava inferior 2 (2%) 2 (2%) NS
Risk factors
Cancer 29 (29%) 40 (40%) NS
Earlier VTE 36 (36%) 28 (28%) NS
Immobilization 22 (22%) 51 (50.5%) < .0001
Surgery/trauma 28 (28%) 53 (52.5%) < .0003
Idiopathic 15 (15%) 12 (12%) NS
VTE, Venous thromboembolism; NS, not significant.
probability result, an angiographic examination was sched-
uled. Major bleeding was defined as a drop in hemoglobin
of more than 2 mmol/L, the need for transfusion of 2
units of packed red cells, cerebral hemorrhage, or
retroperitoneal or joint bleeding. In patients who died, the
cause of death was confirmed either from the death cer-
tificate or by means of necropsy.
Statistical analysis. The differences between patient
characteristics and outcomes were calculated by using
Statview statistical software (Statview 4.0, Abacus
Concepts, Berkeley, 1994). The Fisher exact test was used
as a means of calculating frequencies by 2 × 2 tables, and
the Student t test was used as a means of calculating con-
tinuous variables after testing for normal distribution.
RESULTS
From Nov 1, 1998, to Aug 15, 1999, acute DVT was
diagnosed in 202 consecutive patients (81 men, 121
women). The median patient age was 64 years (range, 12-
95 years). A total of 117 patients (58%) were referred as
outpatients, and 85 patients (42%) were hospitalized
before diagnosis for reasons other than leg symptoms. Of
these, 14 patients had been admitted before DVT diagno-
sis for confirmed PE. Of the 117 outpatients, 95 (81%)
were selected as being eligible for home treatment; 92
patients (79%) were not admitted to hospital at all, and
three patients, who were admitted for hospital time sched-
ule reasons, were discharged within 48 hours after diagno-
sis. Of 85 inpatients, only 7% could be discharged within
the first 48 hours after diagnosis. Ultimately, 101 patients
(50%) were selected as being eligible for home treatment,
and 101 patients remained in the hospital for more than 2
days (Fig). A total of 139 patients kept all five follow-up
appointments, 24 patients kept four follow-up appoint-
ments, and 11 patients kept three follow-up appointments.
All these patients kept the final follow-up appointment
after 3 months. Twenty-eight patients died before the 3-
month follow-up examination was completed.
Reasons for hospitalization. Medical problems
other than DVT, as assessed by the referring physician,
were the reason for hospitalization in all previously hospi-
talized patients. Two of 117 outpatients (2%) were admit-
ted because of DVT morbidity, and one patient was
admitted because of pneumonia. Another 11 of the 117
outpatients (9%) were hospitalized mainly because of an
unfavorable home care situation or their own preference:
seven patients as assessed by the diagnosing physician, two
patients elected to be hospitalized, another patient was
hospitalized because of uncertain compliance, and the
final patient was hospitalized because of the distance to
the GP. Eleven outpatients (9%) were hospitalized for rea-
sons of hospital logistics: seven patients came during
weekends or holidays, and four patients came after 5 p.m.
during the week. Eight of these patients remained in the
hospital for more than 48 hours. None of the patients was
admitted because of the decision of the GP. A review of all
the reasons for hospitalization is given in Table I.
The mean length of hospital stay for patients admitted
because of the home care situation was 8 days (range, 5-
12 days), and for inpatients with conditions not related to
DVT, it was 13 days (range, 3-38 days) after diagnosis.
Patient characteristics and outcome according to
treatment groups. Table II shows the details of the
patient characteristics after applying the diagnostic algo-
rithm in the two groups. The hypercoagulable state was
not known at the time of examination in our patients. For
outcome measures (Table III), the incidence of clinically
significant PE, recurrent DVT, and minor and major
bleeding between outpatients and inpatients was compara-
ble. Symptomatic recurrent VTE was documented in eight
patients (4%), five on home treatment and three during
inpatient treatment. Five patients had recurrent DVT,
three patients had nonfatal PE (1.5%), and two patients
had both conditions. Two clinically symptomatic cases of
PE occurred on days 2 and 5 in the hospital and were con-
firmed with a high-probability lung scan. One such event
occurred on day 68 at home after anticoagulation therapy
had been discontinued by the GP. No cases of major
bleeding occurred. The 3-month mortality rate was 19%
in hospitalized patients and 8% in outpatients (P < .02). Of
the inpatients, 12 died of cancer and 6 died of other dis-
eases. One 82-year-old woman with various medical con-
ditions died after thrombolysis for life-threatening PE 5
hours after admission.
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Flow chart summarizing patient treatment.
Six outpatients (75%) died of cancer, one patient had
septic shock, and another patient died of acute pancreatitis.
DISCUSSION
This study for the first time systematically investigated
the eligibility for home treatment in a cohort of consecu-
tive patients with lower-extremity DVT that was proven by
means of ultrasound scanning.
In earlier studies, a significant portion of patients were
excluded for various reasons.7-11 Differences in patient
characteristics between patients eligible for home treat-
ment or patients requiring in-hospital treatment have not
been investigated thus far.
Outpatient treatment was not randomized in this
study. After the results of the two large home treatment
trials with LMWH7,8 and our own results showing in a
randomized setting that bed rest for DVT being treated
with LMWH is not useful,6 we saw no further reason to
randomize patients to home treatment or hospital treat-
ment in our investigation.
The main finding of this study is that virtually no
patient with DVT who is an outpatient has to be hospital-
ized for medical reasons. In contrast, more than 90% of
previously hospitalized patients have to be treated within
the hospital because of a comorbidity, such as cancer diag-
nosis and treatment, recent surgery, or earlier confirmed
oxygen-dependent PE.
For outcome measures, our results are comparable
with those of other studies. Recurrent VTE was revealed
in 3% of the patients by means of follow-up examination;
no major bleeding and a mortality rate of 13% was
revealed during 3 months follow-up. In 1999, Lensing et
al published a meta-analysis of 13 trials in which patients
received LMWH treatment.5 In these patients, sympto-
matic recurrent VTE occurred in 4.2%, major bleeding in
1.1%, and death in 5.2%.
According to our data, the 3-month mortality rates
were significantly higher in inpatients than in outpatients
(19% vs 8%; P < .02). The main reason was a higher pre-
existing morbidity rate in inpatients; in this group, signif-
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icantly more patients were immobilized or had suffered
trauma or undergone surgery, and more patients had
malignant disease. There was no difference in the preva-
lence of proximal DVT; however, the higher prevalence of
iliac thrombosis in inpatients may be explained by severe
comorbidity.
Our findings point to two further issues. First, the
organization of home care should be improved. In all
prospective home treatment studies, a nurse involved in
the study was available for home care of the patients. This
is not the case in the daily routine outpatient setting every-
where. In our cohort, professional home care was not
available in about 10% of cases of patients with DVT. This
has to be estimated by taking into account a lack of expe-
rience with outpatient care management in DVT in the
geographical area, because traditionally all patients with
acute proximal DVT were hospitalized. Patients hospital-
ized because of the home care situation were all of old age,
and most of them were hospitalized because they lived
alone without relatives nearby. The initial treatment of
patients admitted because of the home care situation was
performed entirely in the hospital. We are convinced that
in areas with a longer tradition of outpatient care and per-
haps a greater financial interest in avoiding hospitalization
because health insurance is lacking, such as in the United
States, the number of admissions because of the home care
situation will be lower. However, we are convinced that
the reasons for admission are the same and only the fre-
quency is different. 
Second, 11 patients were admitted to the hospital for
reasons of management logistics and schedules. Eight of
these patients were hospitalized for more than 48 hours
(mean hospital time, almost 6 days). A urinary tract infec-
tion developed in one patient, and pneumonia developed
in another. The mean duration of hospital stay for the
remaining six patients was 4.5 days. The reasons for hos-
pitalization were persisting management problems after
weekends or holidays. There is no data about hospital ser-
vice logistics in other studies, although the problem is
obviously of major importance.
Table III. Outcome according to treatment status
Outcome after 3 months Outpatients (n = 101) Inpatients (n = 101) P value
Recurrent VTE
Clinically significant PE 1 (1%) 2 (2%) NS
Recurrent DVT 4 (4%) 1 (1%) NS
Both 1 (1%) 1 (1%) NS
Bleeding
Major bleeding 0 0 NS
Minor bleeding 1 (1%) 2 (2%) NS
Mortality
Thromboembolism 0 1 (1%) NS
Cancer 6 (6%) 12 (12%) NS
Other medical disease 2 (2%) 6 (6%) NS
All causes 8 (8%) 19 (19%) < .02
VTE, Venous thromboembolism; PE, pulmonary embolism; DVT, deep vein thrombosis; NS, not significant.
Thus, hospital services should be improved to an extent
that allows definitive patient treatment within 48 hours.
In our experience, cooperation with the GP is one of
the main prerequisites for successful treatment in outpa-
tients. No outpatient was hospitalized because of the GP’s
preference. However, most GPs insisted that the patient
be seen in the hospital regularly, so responsibility was
shared. In 17% of the outpatients, the GP felt uncomfort-
able with the initiation of oral anticoagulation treatment
and preferred INR dose adjustment in the vascular unit.
CONCLUSION
Less than 3% of outpatients in whom DVT is diag-
nosed have to be hospitalized for medical reasons. For
home treatment, an infrastructure that includes diagnostic
facilities, 24-hour emergency department stand-by service,
nursing facilities, and physician service is required.14,15
The great majority of patients in whom DVT develops
within the hospital have to be treated in the hospital
because of morbidity other than thrombosis.
We thank Roswitha Frommhold from our nursing
staff for her excellent patient care and Harry R Büller,
Amsterdam, for his helpful criticism.
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